Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Immune Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01086540
What this trial is testing

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Who this might be right for
Systemic Sclerosis-Associated PAH
National Institute of Allergy and Infectious Diseases (NIAID) 57
Not applicableLooking for participantsNCT06588868
What this trial is testing

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS 400
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Testing effectiveness (Phase 2)Study completedNCT03580655
What this trial is testing

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic MastocytosisAggressive Systemic MastocytosisSystemic Mastocytosis With an Associated Hematologic Neoplasm+1 more
Blueprint Medicines Corporation 107
Not applicableStudy completedNCT01892748
What this trial is testing

Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
ROSA MARIA RODRIGUES PEREIRA 60
Not applicableStudy completedNCT03738826
What this trial is testing

Reducing Disparities in Medication Adherence in SLE

Who this might be right for
Systemic Lupus Erythematosus
Duke University 135
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Early research (Phase 1)WithdrawnNCT06913608
What this trial is testing

Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)
Calibr, a division of Scripps Research
Post-approval studies (Phase 4)Study completedNCT01112215
What this trial is testing

Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations

Who this might be right for
Systemic Lupus Erythematosus
Hospital Universitari Vall d'Hebron Research Institute 240
Not applicableLooking for participantsNCT05038358
What this trial is testing

Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms

Who this might be right for
Primary TumorColon Tumor
University Hospital, Grenoble 60
Large-scale testing (Phase 3)Study completedNCT03131648
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 802
Not applicableStudy completedNCT03103243
What this trial is testing

Pilot Study to Investigate Contemplative Intervention in Lupus Patients

Who this might be right for
Lupus Erythematosus, Systemic
University of Virginia 30
Not applicableUnknownNCT04737343
What this trial is testing

Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis

Who this might be right for
ANCA Associated VasculitisMaintenance Therapy
Chinese SLE Treatment And Research Group 114
Testing effectiveness (Phase 2)Study completedNCT02949349
What this trial is testing

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Genovate Biotechnology Co., Ltd., 32
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Early research (Phase 1)Study completedNCT02609789
What this trial is testing

A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusHealthy
Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Study completedNCT02725515
What this trial is testing

The Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Xencor, Inc. 105
Early research (Phase 1)Looking for participantsNCT07038746
What this trial is testing

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges

Who this might be right for
HypersensitivityAnaphylaxis
Dr. George Luciuk 100
Testing effectiveness (Phase 2)Ended earlyNCT04376827
What this trial is testing

Guselkumab in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 33
Early research (Phase 1)WithdrawnNCT05519527
What this trial is testing

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Who this might be right for
Refractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Next Page